Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
standard obesity coverage eliminated January 1, 2026
The WHO took a more conservative stance, recommending treatment only for clinically obese populations
Compound Semaglutide (Injection) WARNING: RISK OF THYROID C-CELL TUMORS BLACK BOX WARNING: As an alternative to FDA-approved branded products, where appropriate, a provider may prescribe a compounded drug, which is prepared by a state-licensed sterile compounding pharmacy partner
Do You Qualify for GLP-1 Weight Loss
Semaglutide is a single-receptor GLP-1 agonist one of the most clinically studied weight-loss medications available, with an average 15% body weight reduction in trials
US$ 21.28
US$ 25.87
US$ 21.68
US$ 24.35
US$ 28.84
US$ 29.02
US$ 20.61
